Psoriatic arthritis

Soumya M. Reddy, Clifton O. Bingham

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Until recently, psoriatic arthritis (PsA) has not received the same attention as other inflammatory arthritides with regards to the development of formal outcome measures, in part due to the difficulty of studying such a heterogeneous disease.As a result,many of the treatments, as well as outcome measures, used in the evaluation of PsA have been borrowed from the study of rheumatoid arthritis (RA) and ankylosing spondylitis (AS). Indeed, there are currently very few instruments that are diseasespecific for the evaluation of PsA. In this chapter we will review the existing indices that have been applied to PsA from other disease states and review those that have been further validated in this disease.Outcome measures specifically designed for the evaluation of PsA will also be reviewed. The need for disease-specific measures is highlighted by the development of new medications and the need for formal validated outcome measures for use in future clinical trials.

Original languageEnglish (US)
Title of host publicationPsoriasis and Psoriatic Arthritis
Subtitle of host publicationAn Integrated Approach
PublisherSpringer Berlin Heidelberg
Pages95-107
Number of pages13
ISBN (Print)3540212809, 9783540212805
DOIs
StatePublished - Dec 1 2005

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Psoriatic arthritis'. Together they form a unique fingerprint.

Cite this